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Abstract
P-Cell mass, hexokinase/glucokinase (HK/GK) activity, 
glucose metabolism and insulin secretion were studied in 
the islets of rats with fructose-induced insulin resistance 
(IR). Normal male Wistar rats were fed a standard 
commercial diet and water without (control, C) or with 
10% fructose-rich diet (FRD) for 3 weeks. Blood glucose 
(strips), triglyceride (commercial kit), and insulin (RIA) 
levels were measured at the time of death. Glucose-induced 
insulin release, glucose metabolism (14COa and 3H2O 
production from d-[U-14C]- and d-[5-3H]-glucose) and 
HK/GK activity (G-6-P production), transcription (RT- 
PCR), protein expression (Western blot), and cellular 
compartmentalization were measured in isolated islets 
(collagenase digestion). FRD rats presented normoglycemia 
but impaired glucose tolerance, hypertriglyceridemia, 
hyperinsulinemia, and increased HOMA-IR index. In these 
rats, P-cell mass decreased significantly by 33%, with a 44% 
increase in the percentage of apoptotic cells. Glucose- 
induced insulin release and islet glucose metabolism were 
higher in FRD rats. While GK activity (total and cytosolic 
fraction) and protein expression were significantly higher in 
FRD islets, HK showed no change in any of these 
parameters. Our results demonstrate that the changes 
induced by dietary-induced IR upon P-cell function and 
mass are strongly conditional on the nutrient model used. 
In our model (intact animals with impaired glucose 
tolerance), GK activity increases through mechanisms 
previously shown only in vitro or under highly hypergly­
cemic conditions. Such an increase plays a pivotal role in the 
adaptive increased release of insulin in response to IR, even 
in the presence of marked P-cell mass reduction.
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Introduction
Glucose homeostasis depends on the balance between insulin 
levels and the response ofperipheral tissues to insulin action; it 
can remain normal even when insulin action decreases due to 
a compensatory increase in P-cell insulin release (Kahn et al. 
1993). This increase depends on the combination of a higher 
secretory capacity of individual P-cells and an increase in the 
number of such cells. The former is related to an increased 
sensitivity of P-cells to glucose stimulus (Marynissen et al. 
1990, Chen et al. 1993), whereas the mechanism of the latter 
has not been completely elucidated. Failure of P-cell 
adaptation to the increased demand of insulin will result in 
impaired glucose homeostasis and, in time, development of 
type 2 diabetes (Weyer et al. 1999). The homeostatic failure 
involves two progressive defective processes, namely, insuffi­
cient release of insulin (Porte 1991) and decrease in P-cell 
mass (Ogilvie 1933, Klöppel et al. 1985, Butler et al. 2003).
Evidence in the literature has shown that glucokinase (GK) 
activity plays a pivotal role upon islet glucose metabolism and 
insulin secretion. As opposed to other hexokinases (HK), 
GK kinetics shows a cooperative glucose dependence 
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(Hill coefficient 1'7), low affinity for glucose, and the lack of 
end-product inhibition by glucose-6-phosphate (Magnuson 
& Matschinsky 2004). Due to these properties, GK responds 
quickly to changes in glucose concentrations under physio­
logical conditions, thus becoming suitable to act as a glucose 
sensor (Matschinsky & Davis 1998).
Chen et al. (1994ii) have shown that islets isolated from rats 
with hyperinsulinemia induced by continuous 48-h perfusion 
with 50 or 20% glucose, release more insulin in response to 
glucose and have an incremented catalytic GK activity, with 
or without a concomitant increase in GK protein content. 
GK activity, glucose usage and glucose-stimulated insulin 
release have also been causally and linearly related in rat islets 
cultured for up to 7 days with different glucose concentrations 
(Liang et al. 1992). This evidence, however, was obtained in 
the presence of marked hyperglycemia or a high glucose 
concentration in the medium.
On the other hand, islets of rats with spontaneous insulin 
resistance (IR), normal fasting blood glucose and oral glucose 
tolerance test presented hyperinsulinemia and exhibited a 
higher rate of glucose-stimulated insulin secretion in vitro 
together with a significant increase in GK activity, without
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changes in GK protein expression (Chen et al. 1994b). These 
results suggest that factors other than glucose also modulate 
the enzymes activity. Thus, the mechanism by which IR 
triggers selective changes in GK activity and/or protein 
content to maintain glucose homeostasis within normal range 
also remains unclear.
It has been shown that GK activity is dependent of multiple 
modulators, such as its protein mass, its glucose-induced 
compartmentalization within P-cells (Tiedge etal. 1999, Stubbs 
et al. 2000, Rizzo et al. 2002) and, possibly, its interaction with 
the bifunctional regulatory enzyme 6-phosphofructo-2- 
kinase/fructose-2,6-bisphosphatase (PFK-2/FBPase-2; Massa 
et al. 2004). These operating mechanisms have been proved in 
islet cells and cell lines, but there is no evidence for their 
occurrence in intact animal models with IR, normoglycemia 
and impaired glucose tolerance (IGT).
Concerning the mechanism for the adaptation of P-cells to 
an increased demand of insulin, Terauchi et al. (2007) have 
postulated that GK might be a common link between IR and 
the regulation of P-cell mass and function. To prove this 
hypothesis, these authors induced an IR state by adminis­
tration of a high-fat diet (HFD) to either normal wild or 
GK+/ mice. Although their results are highly attractive, it is 
not clear whether they are merely concerned with the islets 
response to IR, or if they also depend on the metabolic 
changes induced by the HFD administration.
In an attempt to better understand the broad mechanisms 
involved in P-cell adaptation to an increased demand of 
insulin, we studied P-cell mass, insulin secretion, glucose 
metabolism, and the activity, transcription, protein 
expression, and intracellular translocation (cellular cytosolic 
and particulate fractions) of HK and GK in islets isolated from 
rats fed with a fructose-rich diet (FRD), a dietary model that 
induces IR (Thorburn et al. 1989, Bezerra et al. 2000, 
Shulman 2000, Catena et al. 2003, Delbosc et al. 2005, 
Rebolledo et al. 2008).
Materials and Methods
Chemicals and drugs
Collagenase was obtained from Serva Feinbiochemica 
(Heidelberg, Germany), BSA (BSA, fraction V), and other 
reagents were from Sigma Chemical Co., Fructose was obtained 
from Corn Products International Inc., (Westchester, IL, USA).
Experim ent al grot ips
Normal male Wistar rats (180—200 g) were divided into two 
groups; the treated group had free access to a standard 
commercial diet plus 10% fructose (w/v) in the drinking 
water (FRD), and the other received the same solid diet and 
tap water (control, C) for 3 weeks. Water and food intake 
were measured daily, while individual body weight was 
recorded once a week. Animal experiments and handling 
were performed according to the ‘Ethical principles and 
guidelines for experimental animals’ (3rd Edition 2005) from 
the Swiss Academy of Medical Sciences (mail@samw.ch).
Blood measurements
At the end of the 3-week period of FRD feeding, blood 
samples were collected (0900 h) from the orbital plexus under 
light halothane anesthesia to measure plasma glucose, 
triglyceride and insulin levels. Glucose was measured with 
test strips (One touch Ultra, Lifescan, Milpitas, CA, USA) 
and triglyceride levels were assayed with commercial kits 
implemented in an automated clinical analyzer. Plasma insulin 
was measured by RIA (Herbert et al. 1965) using an antibody 
against rat insulin, rat insulin standard (Linco Research Inc., 
St Charles, MO, USA) and highly purified porcine insulin 
labeled with ~'I (Linde et al. 1980). IR was assessed with the 
HOMA-IR index, calculated as insulin (j.lU/1) X glucose 
(mmol/1)/22• 5 (Matthews et al. 1985, Nandhini et al. 2005).
I.p. glucose tolerance
The day before the animals were killed, glucose tolerance was 
measuredin 12-h fasted rats after i.p. glucose injection (1 g/kgin 
saline). Blood samples were obtained from the orbital plexus at 0, 
15, 30, 60, and 120 min following the i.p. glucose load, under 
pentobarbital anesthesia (48 mg/kg). Results were expressed 
as the area under the glucose curve (AUC) in mmol/1 per min.
Pancreas removal and islet isolation
After blood collection, the animals from both groups were killed 
(0900 h) by cervical dislocation. The pancreas from each animal 
was removed to isolate islets by collagenase digestion (Lacy & 
Kostianovsky 1967). To study GK and HK activity, isolated islets 
were homogenized in 50 mM HEPES—NaOH buffer (pH 7'5) 
with 6 mM MgCl2, 60 mM KC1, 10 mM KPO4H2, 1 mM 
EDTA, 1 mM 1-cysteine, and 0-02% BSA; to measure protein 
expression the islets were homogenized in 8 0 mM Tris (pH 6'8), 
5 mM EDTA, 5% SDS, 5% dithiothreitol, 10% glycerol and 
protease inhibitors (1 mM phenyl-methylsulfonyl-fluoride, 
4 mg aprotinin, and 0-1 mM benzamidine). Part of both 
homogenates was centrifuged for 5 min at 5000 g to remove 
intact cells and cell debris, and the supernatant was then 
centrifuged for 90 min at 4 °C at 100 000 £ to separate the 
particulate (pellet) and cytosolic (supernatant) fractions. The 
pellet was then suspended in 150 pl of the specific assay buffer. 
Protein concentration from the different fractions (homogenate, 
particulate, and cytosolic) was quantified using the Bio-Rad 
protein assay (Bradford 1976).
Insulin secretion in vitro
Groups of five islets were incubated for 60 min at 37 °C in 
0-6 ml Krebs—Ringer Bicarbonate buffer (KRB) (pH 7-4), 
previously gassed with CCG/CG (5/95%), containing 1%
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(w/v) BSA and different glucose concentrations (2, 4, 8, 12, 
16, and 20 mM; Gagliardino et al. 1974). At the end of the 
incubation period, aliquots from the medium were taken to 
measure insulin by RIA (Herbert et al. 1965).
Glucose oxidation and utilization
Groups of 20 islets were incubated in a small tube containing 
40 pl KRB buffer supplemented with 10 mM HEPES 
(pH 7-4), D-[U-14C]-glucose, and D-[5-3H]-glucose 
(lOMCi/ml, (300 MCi/mmol)) in the presence of 3-3 or 
16'7 mM glucose. This tube together with an empty one was 
placed inside an airtight-sealed 20 ml glass vial containing 
500 pl distilled water in the bottom. After 2-h incubation at 
37 °C, the reaction was stopped by injecting 20 pl of 
400 mM citric acid, 10 mM rotenone, 10 mM antimycin, 
and 3 mg KCN (pH 4-9) to the incubation media; at the 
same time 250 pl hyamine were added to the empty tube. 
After a second incubation for 60 min at 37 °C, the 14CC>2 
fixed to hyamine was measured in vials containing 5 ml 
scintillation liquid (Ultima Gold XR, Packard Waltham, 
MA, USA). The islets were further incubated overnight at 
room temperature and glucose utilization was measured as 
3H2O production captured by water in 5 ml scintillation 
liquid (Malaisse & Sener 1988).
HK/GK activity
Groups of 20 isolated islets (1 islet/pl) were homogenized and 
processed as described above; 20 pl of the whole homogenate 
were then combined with another 20 pl of the reaction 
mixture (HEPES-NaOH, 10 mM ATP, 20 MCi/ml 
(300 MCi/mmol) of D-[U-14C]-glucose, and 1—100 mM 
unlabeled D-glucose) and incubated for 60 min at 37 °C. 
The pellet or the cytosolic fraction of islet homogenates was 
incubated under the same conditions but with 1 or 100 mM 
unlabeled D-glucose. The reaction was stopped by addition of 
1 ml iced water, and each sample was then passed through a 
column of AG 1-X8 to separate D-[U-14C]-glucose-6- 
phosphate fromD-[U-14C]-glucose by ion exchange chroma­
tography (Giroix et al. 1984). The hexose phosphate was 
eluted from the column with 1 M ammonium formate/ 
0-1 M formic acid. The eluate was then mixed with 10 ml 
scintillation fluid, measuring its radioactivity in a liquid 
scintillation spectrophotometer. The same mixture but 
without islet tissue was used as a blank. Under these 
conditions, the G-6-P production obtained in the presence 
of 1 and 100 mM unlabeled glucose corresponded to 
HK and GK activity respectively. HK and GK kinetics 
studies were conducted with the same procedure, but using a 
wide range of glucose concentrations (1—100 mM). GK 
kinetic parameters were fitted to the Hill equation 
I’ = r'’max(Glc)/i/(KQ 5 + (Glc)“). where I’ is the reaction 
rate normalized to the enzyme concentration, (Glc) is the 
glucose concentration, Ktl 5 is the glucose concentration at 
half-maximal activity, and h is the Hill coefficient, which 
indicates the level of glucose cooperativity. Since HK exhibits 
Michaelis—Menten kinetics, to measure its Km and Ij^x we 
used the Eadie—Hofstee plot (iy = Km X v-JS + IjJ, where iy 
is the initial velocity and S is the substrate concentration.
Isolation of total RNA and expression of HK and GK mRNA 
Total RNA was separately obtained from C and FRD rat islets 
using TRIzol Reagent (Gibco-BRL; Chomczynski & Sacchi 
1987). The integrity of isolated RNA was checked by 1% 
agarose—formaldehyde gel electrophoresis (Sambrook et al. 
1989). Possible contamination with protein or phenol was 
controlled by measuring the 260/280 nm absorbance ratio, 
while DNA contamination was avoided using DNAase I 1U/ 
ml (Gibco-BRL). RT-PCR was performed using the Super 
Script III reverse transcriptase (200U/ml; Gibco-BRL) and 
total RNA (50 ng) from C and FRD islets as template. We 
used specific primers based on the rat cDNA sequence to 
measure GK and HK mRNA (GenBank accession numbers: 
GK, M25807, sense primer: 5'-AGGCCACCAAGAAG- 
GAAAAG-3', antisense primer: S'-TTGTCTTCACGC- 
TCCACTGC-3' (Schuit et al. 1999); HK, J04526, sense 
primer: 5/-GGCTCAGAGGAGACCCTTCG-3/, antisense 
primer: 5'-CCAGGTCGAACTTGAATCAT-3' (Jonas 
etal. 1999).
a-Tubulin (JOO797) was used as internal control (sense 
primer: 5/-CTCGCATCCACTTCCCTC-3/, antisense pri­
mer: 5'-ATGCCCTCACCCACGTAC-3';Jonas etal. 1999). 
Possible contamination with genomic DNA was checked 
by performing RT-PCR with or without the SuperScript 
III RT.
The cycling profile for GK was the following: 2-5 min at 
95 °C followed by 1 min at 94 °C, 1'5 min at 65 °C, and 
1-5 min at 72 °C for 10 cycles; and 0-5 min at 94 °C, 1 min at 
60 °C, and 1-5 min at 72 °C for 21 cycles, resulting in a total 
number of 31 cycles (Schuit et al. 1999).
PCR conditions for HK were 10 min denaturing step at 
94 °C, followed by 1 min at 94 °C, 1 min at 55 °C, and 1 min 
at 72 °C for 33 cycles, and a final extension step of 10 min at 
72 °C. Under these conditions, the PCR was in the linear 
range of amplification. PCR products were separated by 
electrophoresis on a 2% (w/v) agarose gel and stained with 
ethidium bromide. Band density was measured using a Kodak 
DC290 digital camera and the Kodak ID Image Analysis 
Software.
ILfefenz blot
Proteins from islet homogenate, cytosol, and particulate 
fractions (10, 10, and 2 ng respectively) obtained from both 
experimental groups were fractioned on reducing 7'5% 
SDS-PAGE and electroblotted to polyvinylidene difluoride 
membranes. Non-specific binding sites were blocked with 
a non-fat milk solution at 4 °C. Measurement of HK and 
GK protein levels was performed by immunoblots using 
the specific primary antibodies against HK (mouse anti-type
www.endocrinology-journals.org Journal of Endocrinology (2009) 200, 139-149
Downloaded from Bioscientifica.com at 08/23/2019 09:44:12PM
via free access
142 b MAizTECui and others ■ Islet glucokinase in insulin resistance
1 HK monoclonal antibody, Chemicon International Inc., 
Temecula, CA, USA) or GK (sheep anti-GST—GK fusion 
protein antibody, kindly provided by Dr Mark Magnusson, 
Vanderbilt University, Vanderbilt, TN, USA) at a 1:2000 
final dilution. After rinsing with tris buffered saline, the 
membranes were further incubated with the streptavidin­
peroxidase conjugate anti-mouse or anti-sheep IgG and 
rinsed in TBS. Diaminobenzidine (Sigma Co.,) and 
electrochemiluminescence (Amersham Biosciences) were 
added for color or chemiluminescence development respect­
ively. Band density was measured as described above.
Immunoh is to chemi cal studies
The whole pancreas was carefully dissected and removed from 
each experimental group, and its wet weight was recorded. 
The pancreas was then fixed in 10% formaldehyde and 
embedded in paraffin. Serial sections of fixed pancreas (5 J.lm) 
were cut from three different depth of the blocks with a 
rotatory microtome and mounted on silanized slides 
(3-amino-propyltriethoxy-silane; Sigma Co., Hsu et al. 
1981). Sections were deparaffinized, incubated for 30 min 
in 3% hydrogen peroxide in methanol to block the 
endogenous peroxidase activity, and rehydrated in a descend­
ing ethanol series, followed by incubation in 2-5% porcine 
serum to reduce non-specific binding. The slides were then 
incubated for 24 h at 4 °C in a humidified chamber with our 
own anti-guinea pig insulin antibody (1:20 000). The final 
staining was performed by incubating the slides for 30 min 
with appropriately diluted streptavidin—biotin complex (1:40 
and 1:20 respectively; Sigma); thereafter, the sections were 
stained with hematoxylin.
Morphometric analysis
Morphometric analysis was performed by videomicroscopy 
using a Jenamed 2 Carl Zeiss light microscope and an RGB 
CCD Sony camera, together with the OPTIMAS software 
(Bioscan Incorporated, Edmons, WA, USA). We measured 
the following parameters: total pancreatic area (excluding 
connective tissue), exocrine, and endocrine pancreatic area; 
P-cell area; the number of P-cells, the number of islets per 
unit area, and single islet volume. We also estimated volume 
density and individual size of P-cells. To estimate islet P-cell 
mass, we multiplied the respective volume densities by the 
weight of the total pancreas (Bonner-Weir & Smith 1994). 
were incubated for 1 h with the insulin antibody. To measure 
the fluorescence labeling of the primary antibody, the slides 
were incubated at room temperature for 45 min in the 
darkness chamber with the IgG-specific, fluorescein-con- 
jugated, affinity-purified goat antibody (against heavy and 
light IgG chains; Jackson Immuno Research Laboratories, 
Baltimore, MD, USA). Following a wash with PBS, sections 
were mounted in Tris—glycerol (pH 8-4) for analysis with a 
fluorescence microscope. Using this double labelling 
procedure, we identified P-cell apoptosis with an immuno- 
fluorescent Zeiss Axiolab epifluorescence microscope 
equipped with an HBO50 mercury lamp, together with 
two different filters. For the quantitative evaluation of 
apoptosis, positively immunofluorescence-labeled P-cells 
were counted under a 40 X objective lens in sections 
obtained from different levels of the blocks. The number of 
apoptotic P-cells was expressed as the percentage of the total 
number of P-cells counted.
Calculations and statistical analysis
Results of HK and GK protein expression and activity from 
the cytosol and the particulate fractions were calculated as a 
percentage of each one with respect to total band intensity or 
a total activity (sum of the measurements of both fractions) 
respectively.
The experimental data were analyzed using the Students 
f-test. Differences were considered significant when P<0-05.
Results
Body weight and water intake
After the 3-week treatment, comparable body weights were 
recorded in both groups of rats (C and FRD, 261-50 + 2'51 
and 262-60 + 2-42 g; NS). FRD rats drank a significantly 
larger volume of water than C (C and FRD, 25-00 + 2-50 and 
39-80 + 1-80 ml/day; P<0-001). Conversely, the amount of 
solid food ingested was significantly greater in C when 
compared with FRD rats (19-26 + 1-52 and 13-37 + 
1'30 g/animal/day respectively; P< 0'001). This fact resulted 
in a different percent daily intake of nutrients in C compared 
with FRD (carbohydrates: proteins: lipids, 45:43:12 and 
60:31:9 respectively), and a comparable caloric intake (C and 
FRD, 55-65 + 4-54 and 50-79 + 3-43 Kcal/day; NS).
Apoptotic fl-cells
We used the propidium iodide technique to identify apoptotic 
bodies (Scaglia et al. 1997). Pancreas sections were depar­
affinized, rehydrated, and then incubated for 30 min in a 
darkness humidified chamber with a propidium iodide 
(4 J.lg/ml; Sigma) and ribonuclease A (100 J.lg/ml; Sigma) 
solution. Then, the sections pre-treated with guinea pig 
non-immune sera diluted in Tris-buffered saline (pH 7'4)
Blood glucose and serum insulin levels
There were no significant differences in blood glucose levels 
between groups (C and FRD, 130-80 + 4-40 and 131'60 + 
3-20 mg/dl; NS). However, FRD rats had significantly higher 
serum insulin (C and FRD, 0-77 + 0-05 and 1-15 + 
0'07 ng/ml; P< 0'001) and plasma triglyceride (C and 
FRD, 98-40 + 3-50 and 158-90 + 5-50 mg/dl; P<0-001) 
levels. As a consequence of the uneven changes of glucose
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and insulin levels in both experimental groups, the insulin: 
glucose molar ratio was 1-83X10 8+ 1'49X10 9 and 
2-67 X IO-8 + 1-76 X 10 9 for C and FRD rats respectively 
(P<0-001). All these parameters were measured in samples 
collected at 0900 h from randomly selected animals of both 
groups.
The IR index (HOMA-IR) was significantly higher in 
FRD animals (C compared with FRD, 5-45 + 0-46 and 
9-02 + 0-68, P< 0-001), thus indicating the presence of an IR 
state in these rats.
Glucose tolerance test
Comparable blood glucose values were measured at time 0 in 
both groups of animals, but these values were significantly 
higher in FRD rats after the i.p. glucose load at 15, 30, and 
60 min. At 120 min, glucose values returned to those initially 
measured (0 time), being similar in both groups of rats 
(Fig. 1). Consequently, the AUC was significantly higher in 
FRD than in C animals (C versus FRD, 1-56 + 0-64 and 
4-29 + 0-49 mmol/1 per min; P<0'01).
Insulin secretion in vitro
Islets isolated from both groups increased the release of insulin 
as a function of the glucose concentration in the incubation 
media (Fig. 2). FRD rat islets released significantly larger 
amounts of insulin than C rat islets in response to stimulatory 
glucose concentrations (8, 12, 16, and 20 mM), shifting the 
secretion curve to the left. However, no difference was 
recorded at lower glucose concentrations (2 and 4 mM).
Figure 2 Glucose-induced insulin secretion in islets isolated from C 
(full line) and FRD (dotted line) rats. ♦ and ■ represent means + 
s.e.m. of five different experiments. *P<0-05, **P<0-02, 
***P<0-005, ****P<0-001.
production was significantly higher (47%) in FRD compared 
with C rat islets (Fig. 3A). On the other hand, 3H2O 
production followed the same trend, being significantly 
higher in FRD islets (61%) in the presence of either a low- 
or high-glucose concentration (Fig. 3B).
HK and GK activity
In our assay, the glucose phosphorylation rate measured in islet 
homogenates up to 1 mM glucose represents an HK enzyme 
activity with a Km of 110 LlM for glucose; whereas the rates
25
Glucose oxidation and utilization
A
In both experimental groups, the production of 14CC>2 from 
D-[U- 'C]-glucose and of TRO from D-p-^HJ-glucose by 
isolated islets increased significantly when the glucose 
concentration in the incubation medium raised from 3-3 to 
16'7 mM (Fig. 3). In the presence of high glucose, 14COa
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Figure 3 (A) Glucose oxidation and (B) utilization measured as 
14CO2 produced from D-[U-14C]-glucose and 'H ,O from d-[5-3H]- 
glucose respectively. Bars represent means + s.E.M. of four different 
experiments performed with islets isolated from each experimental 
group. *P<0-05, **P<0-005, ***P<0-025. White bars, C rats; 
black bars, FRD rats.
Figure 1 Blood glucose concentration at 0, 1 5, 30, 60, and 120 min 
following an i.p. glucose load (1 g/kg body weight) in C (full line) 
and FRD (dotted line) rats. Values represent means + s.E.M. of three 
different experiments performed with six animals in each group. 
*P<0-05.
0
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measured at increasing glucose concentrations (up to 100 mM) 
correspond to a GK enzyme, with a Ktl-¡ close to 20 mM.
GK kinetics parameters exhibited the known positive 
cooperativity with glucose (Hill coefficient, C versus FRD,
1- 45 + 0-37 vs 1-99±0-11; NS); Kys and maximal velocity 
(h'max) of GK measured in islet homogenates were 
significantly higher in FRD (C versus FRD, FQJ S, 20-59 + 
0-97 vs 37-74 + 5-41 mM; P<0-05. Hmix, 2-99 + 0-04 vs 
5-12 + 0-41 pmol glucose/pg prot/min; P<0-001). Com­
parable HK Km and r’mix values were measured in C and 
FRD rats (Km, 110 + 30 vs 110 + 0-3 pM, NS; F’mix, 2-41 + 
0-38 vs 2-14 + 0-15 pmol glucose/J.lg prot/min; NS).
GK activity measured in islet homogenates of FRD 
(Fig. 4A) was significantly higher than that of C rats 
(112-50% of control). GK activity measured in the cytosol 
and in the particulate fractions was referred to total activity 
(cytosol + particulate fractions; Fig. 4B). In FRD animals, 
most of the GK activity was measured in the cytosolic fraction 
(highly active form), being significantly higher than in C islets 
(C versus FRD, 36-40 + 5-00 vs 75-50 +11-00%). Con­
versely, GK activity measured in the particulate fraction 
(lowly active form) of FRD islets was low and significantly 
lower than that measured in C islets (C versus FRD, 63-60 + 
12-00 vs 24-50 + 2-20%).
No significant differences in HK activity were found 
between groups either in the homogenate (Fig. 4C) or in the 
cytosol and particulate fractions (Fig. 4D). Consequently, the 
GK/HK activity ratio was significantly higher (130-10%) in 
FRD than in C rats (C and FRD, 0-73 + 0-10 and T68 + 
0-27; P< 0-002).
HK and GK niRNA
There was no significant difference between groups in the 
intensity of the bands corresponding to GK and HK mRNA 
when compared with a-tubulin (C and FRD; GK, 24'15 +
2- 18 and 24-90+ 0-93%, NS; HK, 36-60 + 2-60 and 40-29 +
3- 10%, NS).
Homogenate
CD 1 c CL 1-5 ■
Western blot
Western blot performed in islet homogenates from C and 
FRD rats with specific GK and HK antibodies showed two 
single bands of about 50 and 109 kDa respectively, compatible 
with the molecular weight of these two enzymes. The band 
intensity increased as a function of the protein concentration 
used, supporting the specificity of the immunoreactive 
measurement (data not shown). The intensity of the GK 
band was higher in FRD islet homogenates (C and FRD, 
100-00 + 6-40 and 154-10 + 17-90%; P<0-02; Fig. 5). The 
intensity of the GK band measured in the cytosolic fraction 
was higher in FRD (C and FRD, 36-00 + 2-30 and 67-60 + 
2-60% of the total intensity; P< 0-001). As expected, the 
intensity of the GK band measured in the particulate fraction 
was higher in C animals (C and FRD, 64-00 + 2-30 and 
32-40 + 2-50% of the total intensity; l‘< 0-001; Fig. 5).
Homogenate
Figure 4 Glucose phosphorylation from different islet fractions 
(homogenate, cytosol, particulate) at 100 (GK, A and B) and 1 
(HK, C and D) mM glucose. Bars represent means +s.e.m. of five 
different experiments performed with islets isolated from each 
experimental group. *P<0-005, **p<0-001. White bars, C rats; 
black bars, FRD rats.
Interestingly, the magnitude of the relative changes in the GK 
protein was greater in both P-cell fractions than in whole 
homogenates. No significant difference was found in the 
intensity of the HK band (C and FRD, 100-0 ill-7 and 
99-7 + 11-8%; NS; Fig. 5).
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GK HK
Figure 5 GK and HK expression (western blot) from C and FRD rats measured in islet homogenate, cytosolic, 
and particulate fractions. In all cases, molecular weight standards were used as internal control. Band 
intensities (relative values) are represented under the bands (white bars, C; black bars, FRD). Representative 
blot of four independent experiments. (*P<0-02, **P<0-001).
Homogenate
Morphometric analysis and /3-cell apoptosis
Pancreas weight did not differ between the experimental 
groups. FRD animals showed a significant decrease in the 
number of islets, total endocrine area, P-cell area, P-cell mass, 
single islet volume, islet area, and number of P-cells/islet 
(Table 1 and Fig. 6A and B). On the other hand, the 
percentage of apoptotic P-cells was significantly higher in 
FRD rats (C versus FRD, 0-62 + 0-03 vs 1-11 + 0-04%; 
P<0-05; Fig. 6C-E).
Discussion
Our results show that the administration of a FRD to normal 
rats induces an IR state, as demonstrated by hyperinsulinemia 
with normoglycemia, high insulin: glucose molar ratio, and 
the HOMA-IR index. As reported previously, these rats also 
had significantly increased serum triglyceride levels (Thor- 
burn et al. 1989).
FRD-induced IR is due to the combination of several 
factors, namely, a) reduction in the number of insulin
Table 1 Morphometric analysis of control and fructose-treated rats
Control FRD
Pancreas weight (mg)
Number of islets/mm2
Total endocrine area (%) 
P-cell area (%)
P-cell mass (mg)
Single islet volume (g3)
Islet area (g2) 
Number of P-cells/islet
608 ±88
2-14±0-06
1-13±0-05
1-09±0-04
6-90±1-64
66X103 ±673 
5224±61 
44-73 ±2-47
559±52
1-08±0-17*
0-69±0-1*
0-65±0-03*
3-89±0-50*
31 X103±810* 
3068 ±78* 
29-95±2-31*
Values are means +s.e.m. from three different levels of the block 
corresponding to three animals of each group; *P<0-05. C, control; FRD, 
fructose-rich diet. 
receptors in skeletal muscle and liver (Catena et al. 2003), b) 
alterations at post-insulin receptor level (Bezerra et al. 2000), 
c) increased rate of the free fatty acid—glucose cycle (Randle 
1964, Shulman 2000), and d) increased gluco-oxidative stress 
(Delbosc et al. 2005, Rebolledo et al. 2008).
Rats fed with the FRD showed a significant decrease in the 
number of islets, total endocrine area, P-cell area, single islet 
volume, islet area and number of P-cells/islet, leading to a 
33% decrease in P-cell mass, with a concomitant 44% increase 
in the percentage of apoptotic cells. We should thus assume 
that the increased percentage of apoptosis was not compen­
sated by a similar increase in P-cell replication and neogenesis. 
Apoptosis in these animals could be stimulated by several and 
concurrent processes such as IR-related endoplasmic reticu­
lum stress (Rutkowski & Kaufman 2004) and glucolipotoxi- 
city (Poitout & Robertson 2002, Robertson et al. 2007). With 
reference to the latter process, it has been recently reported 
that adipose tissue of FRD rats releases larger amounts offatty 
acids with a high saturated/unsaturated ratio both in vivo and 
in vitro (Rebolledo et al. 2008); the known enhancing effect of 
saturated fatty acids upon apoptosis would also favor the 
increment of P-cell apoptosis measured in these rats 
(Kharroubi et al. 2004). The apparent discrepancy between 
our results and those of Terauchi et al. (2007) are due to the 
different serum free fatty acids.
A comparable association of decreased P-cell mass and 
increased percentage of P-cell apoptosis has been previously 
described in obese people with impaired fasting glucose and 
type 2 diabetes (Butler et al. 2003). Thus, the data recorded in 
FRD rats support the concept that decreased P-cell mass is an 
early and progressive alteration involved in the pathogenesis of 
type 2 diabetes. These data also suggest that FRD is a useful 
model to study the mechanism/s responsible for the decrease 
of P-cell mass observed in human type 2 diabetes (Ogilvie 
1933, Klöppel et al. 1985, Butler et al. 2003).
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A B
pancreas from C animals shows more islets per area than FRD (1 OX). Apoptosis (red nuclei, arrows) observed 
in islets from C (C) and FRD (D) rats treated with propidium iodide (20X). (E) Percentage of apoptotic 0-celIs 
in C (white) and in FRD (black) rats (means+s.e.m.); * P<0-05. The results represent three different levels of 
the block from three animals of each group.
Despite the marked decrease in P-cell mass, FRD rats had 
normal blood glucose together with high-circulating levels of 
insulin, as well as higher in vitro release of insulin in response 
to glucose. These data indicate that the remaining P-cells 
were still sufficient to cope with the increased demand of 
insulin present in these rats. The fact that these animals had 
significantly higher glucose concentrations than control rats 
after an i.p. glucose load would suggest that total compen­
sation would only be fully effective when the decrease in 
P-cell mass is lower than that found in our model (33%). This 
assumption would be supported by the results obtained using 
partial pancreatectomy, in which the degree of alteration of 
glucose homeostasis is proportional to the percentage of the 
pancreas removed (Jonas et al. 1999).
The increased release of insulin measured both in vivo and 
in vitro in FRD rats was accompanied by a significant 
concomitant increase in islet glucose metabolism, GK activity 
and GK protein expression. GK activity is controlled by 
mechanisms acting at different levels, namely, protein levels 
(Liang et al. 1992) and subcellular compartmentalization with 
translocation between the cytoplasm and P-cell organelles 
(Tiedge et al. 1999, Stubbs et al. 2000, Rizzo et al. 2002). We 
found an increase in total GK protein expression (western blot 
and Izmix) and in GK activity/protein measured in the
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cytosolic fraction, which represents its highly active form 
(Tiedge et al. 1999). These data suggest that GK 
compartmentalization (shuttled from organelles to the 
cytosol) could be the immediate and rapid islet adaptation 
mechanism to cope with the increased demand of insulin 
occurring in FRD rats.
The changes in GK currently recorded resemble those 
observed in comparable but not identical conditions, namely, 
a) increased GK activity measured in spontaneously 
hypertensive rats with IR and normal glucose tolerance, 
without changes in its protein level (Chen et al. 1994b); b) 
increased GK activity reported in short-term hyperinsuli- 
nemic/markedly hyperglycemic rats (Chen et al. I 994(7): c) 
increased GK activity in rats infused with 20% glucose, 
without changes in its protein level (Chen et al. 1994ii), and d) 
high GK activity measured in islets cultured with high glucose 
concentrations (Liang et al. 1992). In our experimental 
model, no difference in blood glucose concentrations was 
recorded between C and FRD rats; however, since the latter 
presented impaired i.v. glucose tolerance, they would have 
mildly higher postprandial blood glucose levels. Conse­
quently, our data show for the first time that in intact animals 
with IGT, the relative low but permanent increase in 
postprandial blood glucose levels is sufficient to trigger the 
increase of both GK activity and protein level, without 
affecting its mRNA levels. This latter effect was not 
completely unexpected, since increased GK protein 
expression without a concomitant increase in its mRNA 
has been reported by several authors (Iynedjian et al. 1989, 
MacDonald 1990, Liang et al. 1992). Based on reported 
evidence and our own data, we could assume that the 
increased protein mass of the enzyme could be ascribed to 
changes at posttranscriptional level in response to the fructose 
overload.
Despite the large and significant number of changes 
observed in GK, no significant change was measured in HK 
activity, mRNA levels and protein expression in the islets of 
FRD animals when compared with C islets.
Regarding the mechanism accounting for the changes 
observed in FRD rats, we hypothesize the following temporal 
sequence of events: a) there is an increase in triglyceride, 
saturated free fatty acids, and postprandial glucose concen­
trations that induce a concomitant increase in gluco-oxidative 
stress and IR (Peyron-Caso et al. 2002, Poitout & Robertson 
2002, Lombardo & Hein 2007); b) these changes promote an 
uncompensated increase in P-cell apoptosis, with the 
consequent decrease in their mass; c) the small but sustained 
increase in postprandial blood glucose would be sufficient to 
trigger an increase in both GK activity and protein level in the 
islets, with the consequent increase in islet glucose 
metabolism and glucose-induced insulin secretion both in vivo 
and in vitro. These adaptive changes would be adequate 
enough to cope with the increased demand for insulin 
imposed by IR only in the case that P-cell mass does not fall 
below a threshold level (certainly lower than 33%). If this 
adaptive mechanism fails to maintain glucose homeostasis, 
fasting, and postprandial hyperglycemia would appear 
promoting — at least in susceptible animals such as the 
DBA/2 mice — a decrease of both GK protein and glucose- 
induced insulin secretion (Kooptiwut et al. 2005). The 
presence of decreased islet GK I rmix values together with high 
blood glucose and normoinsulinemic levels in rats fed for 8 
months with a sucrose-rich diet would support this 
assumption (Ferreira et al. 2007). Therefore, according to 
the magnitude and the time of exposure to high glucose 
levels, glucose can simultaneously decrease P-cell mass and 
sequentially increase GK activity, its protein mass, islet glucose 
metabolism, and insulin secretion, or just turn down all these 
compensatory changes, leading to diabetes development.
Since insulin secretion is a multifactorial modulated 
process, we cannot discard the possibility that other 
mechanisms could also be involved in the compensatory 
response observed in our animals.
There are marked differences in the pattern of P-cell 
changes — mass and function — observed in response to the IR 
state induced by our FRD and by the HFD (Terauchi et al. 
2007) at 3 and 4 weeks after treatment respectively. In both 
studies, hyperinsulinemia was present, but HFD-treated 
animals had normal glucose tolerance. Additionally, while 
FRD animals showed increased islet GK activity, glucose 
utilization, and glucose-induced insulin secretion, the islets 
from HFD mice had no change in GK activity and decreased 
islet glucose oxidation and insulin release in response to 
glucose. Further, FRD rats displayed a decrease in their P-cell 
mass when compared with HFD animals, which exhibited an 
increase in this parameter. Consequently, hyperinsulinemia in 
FRD rats is due to an increase in P-cell function, while in 
HFD-fed animals it might be due to the increased number of 
lower-functioning islets (Terauchi et al. 2007). Based on all 
these differences, we can suggest that the changes induced by 
dietary-induced IR upon P-cell function and mass are 
strongly conditioned by the nutrient model used. A diet 
rich in fructose would exert a deeper and faster deleterious 
effect upon P-cell mass than a fat-rich diet.
In summary, our results provide the first evidence that the 
regulatory mechanisms of GK activity, namely, increment of 
its activity/protein concentration — demonstrated in animals 
with transient-induced hyperglycemia — in cultured islets and 
cell lines, also operate in vivo in a rat model with sustained 
induced IR and IGT but normal fasting glucose levels. These 
results also demonstrate that in a situation similar to the one 
observed in people at risk of developing type 2 diabetes; GK 
plays a pivotal role in the adaptive increased release of insulin 
in response to IR, even in the presence of a marked P-cell 
mass reduction. An impaired participation of GK in this 
process or a larger decrease in P-cell mass would result in a 
severe alteration of glucose homeostasis and diabetes 
development. The decreased transcription of GK in animals 
with long-term high or severe hyperglycemia (Jonas et al. 
1999), the development of diabetes (Froguel et al. 1992, 
Kooptiwut et al. 2005) associated with GK mutations in the 
human pancreas, and the postulated regulatory effect of GK
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upon P-cell mass (Terauchi et al. 2007) would further support 
our assumption. Those results would also lend further support 
to the role of the network of GK-expressing cells in glucose 
homeostasis and the potential use of its activators for diabetes 
prevention and treatment (Matschinsky et al. 2006).
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